Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Topical sirolimus"'
Autor:
Leena HN, Savitha B Raghavan, Yogesh HR, Sujatha Sowmyanarayan, Amberkar Mohanbabu Vittalrao, Abhineetha Hosthota
Publikováno v:
Perspectives In Medical Research, Vol 12, Iss 1, Pp 45-48 (2024)
Introduction: Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder. Facial angiofibromas are the most common cutaneous findings of TSC. Treatment modalities such as laser, surgery, and/or cryotherapy are employed. Topical therapy wi
Externí odkaz:
https://doaj.org/article/d7a1be79927b46179aaae0fac526c216
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-7 (2020)
Abstract Background Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder forming hamartomas throughout the body. Facial angiofibromas (FAs) occur in 75% of TSC patients, which are often enlarged, impairing the appearance of the face
Externí odkaz:
https://doaj.org/article/b3a489e3da63424588307c6c0db8286c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bérenger Largeau, Bruno Giraudeau, Antoine Marchand, Annabel Maruani, Agnès Caille, Hélène Bourgoin, Valérie Gissot, Céline Lengellé, S. Leducq
Publikováno v:
Trials. 23
Background Lingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations presenting as clusters of cysts filled with lymph fluid or blood. Even small well-limited lesions can be responsible for a heavy burden, inducin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8a5407c347821834e844a9d4b3c6c7
https://doi.org/10.1186/s13063-022-06365-y
https://doi.org/10.1186/s13063-022-06365-y
Publikováno v:
Pediatric Dermatology. 38:967-969
Topical sirolimus has become a crucial treatment option for many dermatologic disorders. Because an FDA-approved topical formulation is not commercially available, sirolimus creams, ointments, and gels are professionally prepared by compounding pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffa55ce4b6afc2163cbc2ac2ab455ec5
https://doi.org/10.1111/pde.14637
https://doi.org/10.1111/pde.14637
Autor:
Hironori Niizeki, Chiharu Tateishi, Kazuyoshi Fukai, Shigeki Shimasaki, Yasuyuki Fujita, Izumi Hamada, Tatsuro Takahata, Akihiko Asahina, Yuuki Ohno, Hiroyuki Murota, Hiroo Yokozeki, Masaaki Ogai, Kenji Shimizu, Mari Wataya-Kaneda, Yuichi Yoshida, Kazue Yoshida, Hiroshi Nagai
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 4, Pp 635-650 (2020)
Dermatology and Therapy
Dermatology and Therapy
Introduction Our previous clinical studies have demonstrated the short-term efficacy and safety of the sirolimus gel for patients with tuberous sclerosis complex (TSC). However, long-term clinical evidence is lacking. Our objective was to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa3201100311a69f505849693888027
https://doi.org/10.1007/s13555-020-00387-7
https://doi.org/10.1007/s13555-020-00387-7
Autor:
Melissa Dodds, Marcia Hogeling, Leslie Castelo-Soccio, Megha M. Tollefson, Sheilagh Maguiness, Maria C. Garzon, Christina Boull, Kristen P. Hook
Publikováno v:
Pediatric Dermatology. 37:272-277
Background Systemic sirolimus (rapamycin) has recently been found effective in treating complex vascular anomalies by reducing the size and associated complications. Many vascular anomalies have a cutaneous component, and thus, we sought to determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c6ec2697b352f3e0c64b5661ce20bc2
https://doi.org/10.1111/pde.14104
https://doi.org/10.1111/pde.14104
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-7 (2020)
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-7 (2020)
Background Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder forming hamartomas throughout the body. Facial angiofibromas (FAs) occur in 75% of TSC patients, which are often enlarged, impairing the appearance of the face, and red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd2ce392a777a414b6a506f1c2cc70ae
https://doi.org/10.21203/rs.3.rs-20090/v1
https://doi.org/10.21203/rs.3.rs-20090/v1
